A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Conditions
- Head and Neck Squamous Cell Carcinoma
Interventions
- DRUG: Apatinib plus chemoradiation
Sponsor
Henan Cancer Hospital
Collaborators